Healio.com

@GoHealio

General knowledge has its place. Specialty experience lives here.

Thorofare, NJ
Vrijeme pridruživanja: siječanj 2012.

Tweetovi

Blokirali ste korisnika/cu @GoHealio

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @GoHealio

  1. prije 40 minuta
    Poništi
  2. prije 1 sat
    Poništi
  3. proslijedio/la je Tweet
    Poništi
  4. prije 2 sata

    , although effective at lowering in patients with open-angle , has a low safety profile, according to a study by the Department of Medicine in the University of Udine in Udine, Italy.

    Poništi
  5. prije 3 sata
    Poništi
  6. proslijedio/la je Tweet
    prije 3 sata

    Topline data from randomized phase 2/phase 3 trial: addition of dinutuximab to irinotecan failed to extend overall survival among patients with relapsed/refractory small cell lung cancer, according to manufacturer United Therapeutics

    Poništi
  7. prije 4 sata
    Poništi
  8. proslijedio/la je Tweet
    prije 4 sata

    Congrats to Eileen Smith, MD, hodgkin lymphoma specialist who has been appointed new chair of hematology and hematopoietic cell transplantation - she will take over of Stephen J. Forman, MD, who chaired department for the last 30 years

    Poništi
  9. proslijedio/la je Tweet
    prije 5 sati

    Sanjiv S. Agarwala, MD provides perspective on recently published phase 3 E1609 trial in on Adjuvant low-dose ipilimumab extending overall survival vs. high-dose interferon alfa-2b in metastatic melanoma

    Poništi
  10. prije 5 sati
    Poništi
  11. Poništi
  12. proslijedio/la je Tweet
    prije 6 sati

    Congrats to Hematology scholars Gabriela S. Hobbs, MD & Oluwatoyosi Adefunke Onwuemene, MD who will participate in Harold Amos Medical Faculty Development Program, in partnership with

    Poništi
  13. prije 6 sati

    The Effects of Surgical Treatment on Retina-Choroidal Findings in Patients With Obstructive Sleep Apnea Syndrome:

    Poništi
  14. proslijedio/la je Tweet

    Poor prognostic factors when treating should prompt physicians to add any JAK inhibitor or biologic DMARD, with no preference given to the latter, according to a 2019 update to recommendations for RA

    Poništi
  15. proslijedio/la je Tweet
    prije 6 sati

    Mark Hanna, MD Upland provides Perspective on study recently presented at - Gut bacteria may be factor in rising colorectal cancer incidence among younger adults

    Poništi
  16. prije 7 sati
    Poništi
  17. prije 9 sati
    Poništi
  18. 2. velj
    Poništi
  19. 1. velj
    Poništi
  20. 31. sij
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·